Named Patient Import allows healthcare providers to obtain unlicensed, life-saving drugs for patients under critical circumstances when no other treatments are available. Most countries, including those in Africa, Asia, Europe, and the Middle East, have developed programs like the Named Patient Program or Expanded Access to facilitate this. The named patient program in Bulgaria, offered by Ikris Pharma Network, helps patients and healthcare providers access these treatments for life-threatening conditions.